1419170-27-6

Basic information

• Product Name: 2-[4-(2-carboxyethyl)-5-{5-[3-(2-carboxyethyl)-5-(2-carboxyphenyl)thiophen-2-yl]thiophen-2-yl}thiophen-2-yl]benzoic acid
• Synonyms: 2-[4-(2-carboxyethyl)-5-{5-[3-(2-carboxyethyl)-5-(2-carboxyphenyl)thiophen-2-yl]thiophen-2-yl}thiophen-2-yl]benzoic acid
• CAS NO: 1419170-27-6
• Molecular Weight: 632.736
• Mol File: 1419170-27-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-[4-(2-carboxyethyl)-5-{5-[3-(2-carboxyethyl)-5-(2-carboxyphenyl)thiophen-2-yl]thiophen-2-yl}thiophen-2-yl]benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[4-(2-carboxyethyl)-5-{5-[3-(2-carboxyethyl)-5-(2-carboxyphenyl)thiophen-2-yl]thiophen-2-yl}thiophen-2-yl]benzoic acid(1419170-27-6)
• EPA Substance Registry System: 2-[4-(2-carboxyethyl)-5-{5-[3-(2-carboxyethyl)-5-(2-carboxyphenyl)thiophen-2-yl]thiophen-2-yl}thiophen-2-yl]benzoic acid(1419170-27-6)

Safety Data

• Hazardous Substances Data: 1419170-27-6(Hazardous Substances Data)

Upstream product

• 1419171-82-6 methyl 3-(5-bromo-2-{5-[5-bromo-3-(3-methoxy-3-oxopropyl)thiophen-2-yl]thiophen-2-yl}thiophen-3-yl)propanoate 
• 1419171-81-5 C₈H₉BrO₂S 
• 179932-05-9 3-Thiophen-3-yl-propionic Acid Methyl Ester 
• 16378-06-6 3-(3-thienyl)propanoic acid 
• 1195-52-4 trans-3-(3-thienyl)acrylic acid 
• 1419171-80-4 methyl 3-(2-{5-[3-(3-methoxy-3-oxopropyl)thiophen-2-yl]thiophen-2-yl}thiophen-3-yl)propanoate 
• 1419172-26-1 C₃₆H₃₂O₈S₃ 

Relevant articles and documents

NOVEL COMPOUNDS AND THEIR USE IN THERAPY

The present invention relates to novel chemical compounds formula (I) (C)n-B-(A)m-B-(C)n (I) wherein m is 0 or 1, and n is independently 0, 1, 2 or 3, A, each B and each C are independently selected from phenylene and five-and six-membered heteroaromatic rings, and for a terminal ring B or C also from bicyclic heteroaromatic fused rings having seven to ten ring members, wherein the bond between at least two of the rings A to C may be replaced by a carbonyl group (-CO-), wherein at least two of the rings A to C are substituted with one or two groups R, and wherein each ring A to C further optionally is substituted with one or two groups R1. The compounds are useful in therapy, especially therapy of a mammal suffering from a disease involving misfolded or aggregated forms of proteins.